Our impact can be profound.

When the OSP team works in concert with a client’s leadership, the results show up in revenue, contracts and exits. Two engagements, in their own numbers.

Spinal implants · 2014 to 2018

Emerging Implant Technologies

A German manufacturer of 3D-printed porous-titanium spinal implants launches in the United States, and is acquired by a Johnson & Johnson company within four years.

Read the case study →

$3.5Msales run rate in the first 10 months

National HCAcontract within the first months

Acquiredby DePuy Synthes Spine, 2018

$1M → $40M+revenue growth, 2021 to 2023

Zero findingson FDA inspection

$140Mpotential value, merger with Carmell (Nasdaq: CTCX)

Biologics and wound care · 2018 to 2023

Axolotl Biologix

A ten-person biologics company with a great product and no focused strategy is recapitalized, restructured and grown into a public-company merger.

Read the case study →

Every frontier of management

Each case drew on a different mix. These are the areas we bring to an engagement.